Compass Pathways
CMPS
126 hedge funds and large institutions have $201M invested in Compass Pathways in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 20 increasing their positions, 31 reducing their positions, and 21 closing their positions.
241% more call options, than puts
Call options by funds: $5.93M | Put options by funds: $1.74M
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
62% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 21
12% more capital inflows, than outflows
Capital inflows: $26.1M | Capital outflows: $23.4M
12% more funds holding
Funds holding: 113 → 126 (+13)
1.12% more ownership
Funds ownership: 36.01% → 37.13% (+1.1%)
35% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Paradigm Biocapital Advisors
New York
|
+$5.87M |
| 2 |
Affinity Asset Advisors
New York
|
+$3.56M |
| 3 |
PFM Health Sciences
San Francisco,
California
|
+$1.85M |
| 4 |
ExodusPoint Capital Management
New York
|
+$1.79M |
| 5 |
Sio Capital Management
New York
|
+$1.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AGF Management
Toronto,
Ontario, Canada
|
-$7.56M |
| 2 |
Armistice Capital
New York
|
-$2.96M |
| 3 |
Logos Global Management
San Francisco,
California
|
-$2.91M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.5M |
| 5 |
Deep Track Capital
Greenwich,
Connecticut
|
-$2.43M |
CMPS Hedge Fund Activity: Q4 2023 in Review
126 of the 6,877 institutional investors tracked by Wall St. Rank reported a position in Compass Pathways (CMPS) for Q4 2023, worth a combined $201M — up 22% from $165M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new CMPS positions and 21 closed out — a net gain of 13 holders — while 20 added to existing stakes and 31 trimmed.
The largest buyer was Paradigm Biocapital Advisors, adding an estimated $5.87M. The largest seller was AGF Management, exiting entirely with an estimated $7.56M sold.
- 126 institutional investors held Compass Pathways (CMPS) as of Q4 2023, up from 113 in Q3 2023.
- Funds reported $201M of Compass Pathways stock for Q4 2023, up 22% quarter-over-quarter.
- 34 funds opened new Compass Pathways positions in Q4 2023 and 21 closed out, a net change of +13 holders.
- The largest Compass Pathways buyer in Q4 2023 was Paradigm Biocapital Advisors, an estimated $5.87M added.
- The largest Compass Pathways seller in Q4 2023 was AGF Management, an estimated $7.56M sold.
Based on aggregated 13F filings for Q4 2023.